What should be the endometrial thickness on day 5 of the endometrial cycle to start Progynova (estradiol valerate) for a Frozen Embryo Transfer (FET) cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Endometrial Thickness Target for Starting Progynova in FET Cycles

There is no specific endometrial thickness requirement on day 5 of the cycle to start Progynova (estradiol valerate) for FET preparation—estrogen supplementation typically begins on cycle day 2-3 regardless of baseline endometrial thickness, with the goal of achieving ≥7 mm thickness before progesterone initiation and embryo transfer. 1

Understanding the FET Protocol Timeline

The question appears to conflate two distinct timepoints in FET preparation:

  • Baseline endometrial thickness (day 2-5 of cycle): This measurement has minimal predictive value for FET success. Research demonstrates no significant relationship between baseline endometrial thickness and clinical pregnancy rates 2. One study found baseline thickness averaged 5.0-5.1 mm on cycle day 3, with no difference between successful and unsuccessful cycles 2.

  • Target thickness before progesterone initiation: The critical measurement occurs after estrogen priming, not at baseline. Guidelines recommend achieving endometrial thickness ≥7 mm before proceeding to trigger and progesterone supplementation 1, 3.

Evidence-Based Thickness Targets

Minimum Threshold for Transfer

The consensus threshold is ≥7-8 mm measured at the time of progesterone initiation, not at cycle day 5. Multiple studies support this:

  • Endometrial thickness <7 mm is associated with significantly lower pregnancy rates 3, 4
  • Thickness ≤8 mm correlates with reduced clinical pregnancy rates (24.6% vs 30.3%) and clinical pregnancy rates (18.6% vs 24.0%) compared to >8 mm 5
  • Thickness ≤8 mm shows lower live birth rates (23.8%) compared to 9-13 mm (32.2%) or ≥14 mm (34.0%) 6

Optimal Range

Endometrial thickness of 9-13 mm at time of progesterone start is associated with optimal outcomes 6. Thickness >14 mm does not appear to confer additional benefit 6.

Practical Clinical Algorithm

  1. Initiate Progynova on cycle day 2-3 regardless of baseline endometrial thickness 1

  2. Monitor endometrial development with transvaginal ultrasound during estrogen supplementation, typically around cycle day 10-14 3

  3. Assess both thickness and pattern: Target ≥7 mm with trilaminar pattern before progesterone initiation 1, 3

  4. If thickness <7 mm: Continue estrogen supplementation and reassess in 2-3 days. Consider additional interventions if persistently thin 7

  5. Once ≥7 mm achieved: Initiate progesterone supplementation and schedule embryo transfer according to embryo stage 1

Important Caveats

Baseline Thickness Has Limited Predictive Value

Baseline endometrial thickness on cycle day 3-5 does not predict FET success 2. The response to estrogen supplementation (endometrial thickness change) is what matters, not the starting point 2.

BMI Considerations

Higher BMI shows weak positive correlation with baseline endometrial thickness (r = +0.29), but this does not translate to improved outcomes 2. The mechanism appears independent of estradiol levels 2.

Risk Factors for Inadequate Response

Patients at higher risk for thin endometrium despite estrogen supplementation include those with 7:

  • Lower BMI
  • Nulliparity
  • Previous operative hysteroscopy
  • Fresh cycle endometrial thickness ≤11.5 mm

For patients with fresh cycle thickness ≤11.5 mm, there is 80% sensitivity for inadequate FET cycle thickness, warranting closer monitoring or alternative protocols 7.

Pattern Matters Beyond Thickness

Evaluate endometrial pattern (trilaminar preferred) in addition to absolute thickness, as pattern independently impacts implantation rates 3.

References

Guideline

Modified Natural Cycle FET Protocol Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Optimizing Endometrial Thickness During Letrozole Ovulation Induction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ideal embryo transfer position and endometrial thickness in IVF embryo transfer treatment.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018

Research

The effect of endometrial thickness and pattern on the success of frozen embryo transfer cycles and gestational age accuracy.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021

Research

Endometrial thickness significantly affects clinical pregnancy and live birth rates in frozen-thawed embryo transfer cycles.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016

Related Questions

What is the optimal endometrial thickness for a frozen embryo transfer?
Is a progesterone level of 36.5 nanograms per milliliter (ng/mL) and an estrogen level of 75.4 picograms per milliliter (pg/mL) optimal for frozen embryo transfer in a 31-year-old female with an endometrial thickness of 8.5 millimeters (mm) and a trilaminar pattern, after taking progesterone in oil (Progesterone) and estrogen (Estrogen) therapy?
What's the next step for a Frozen Embryo Transfer (FET) cycle with an endometrial thickness of 9.4 mm on day 4 while starting Progynova (Estradiol)?
What is the best course of action for a patient undergoing Hormone Replacement Therapy (HRT) for Frozen Embryo Transfer (FET) with a current regimen of 12mg Progynova (estradiol) and an endometrial thickness of 7.3mm on day 9?
What is the optimal endometrial thickness for frozen embryo transfer (FET)?
What is the field triage decision scheme?
What is the appropriate dosing of amoxicillin (500mg capsule) for an adult patient with pneumonia, tooth abscess, and wound infection, considering potential impaired renal function and history of allergy to penicillins?
What is the best initial treatment approach for a patient with Guillain-Barré Syndrome (GBS) presenting with facial diplegia?
What is the optimal range for mean arterial pressure (MAP) in adults, particularly those with hypertension, heart failure, or critical illness?
What is the treatment approach for a patient with hydrochloric acid chemical burns?
What is the significance of bacteriuria in a patient's urine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.